Yanping Hu

4.8k total citations · 1 hit paper
117 papers, 1.7k citations indexed

About

Yanping Hu is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yanping Hu has authored 117 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 33 papers in Molecular Biology and 29 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yanping Hu's work include Lung Cancer Treatments and Mutations (24 papers), Lung Cancer Research Studies (15 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Yanping Hu is often cited by papers focused on Lung Cancer Treatments and Mutations (24 papers), Lung Cancer Research Studies (15 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Yanping Hu collaborates with scholars based in China, Canada and United States. Yanping Hu's co-authors include Lawrence D. Mayer, Jacques Robert, Stephen Baird, Jon P. Durkin, Eric C. LaCasse, Robert G. Korneluk, Jun Zhao, Ding Lei, Wieslawa H. Dragowska and Jennifer A. Shabbits and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Yanping Hu

105 papers receiving 1.7k citations

Hit Papers

Tislelizumab Plus Chemotherapy vs Chemotherapy Alone as F... 2021 2026 2022 2024 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanping Hu China 22 750 734 441 334 125 117 1.7k
Likun Chen China 21 484 0.6× 815 1.1× 605 1.4× 297 0.9× 103 0.8× 86 1.5k
Linda E. Kelemen United States 27 632 0.8× 638 0.9× 240 0.5× 353 1.1× 174 1.4× 55 2.2k
Sheng‐Ming Wu Taiwan 25 794 1.1× 381 0.5× 300 0.7× 397 1.2× 138 1.1× 90 1.8k
Junji Matsuoka Japan 28 833 1.1× 853 1.2× 373 0.8× 577 1.7× 178 1.4× 108 2.4k
Feng Lin China 27 605 0.8× 647 0.9× 600 1.4× 318 1.0× 204 1.6× 75 2.0k
Jussi Koivunen Finland 23 775 1.0× 716 1.0× 387 0.9× 192 0.6× 243 1.9× 89 2.1k
Ziwen Liu China 25 969 1.3× 397 0.5× 224 0.5× 421 1.3× 130 1.0× 105 2.2k
Xiaoli Hu China 20 697 0.9× 383 0.5× 201 0.5× 296 0.9× 136 1.1× 41 1.3k
Ming-Shyan Huang Taiwan 23 957 1.3× 401 0.5× 355 0.8× 449 1.3× 194 1.6× 31 1.6k

Countries citing papers authored by Yanping Hu

Since Specialization
Citations

This map shows the geographic impact of Yanping Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanping Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanping Hu more than expected).

Fields of papers citing papers by Yanping Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanping Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanping Hu. The network helps show where Yanping Hu may publish in the future.

Co-authorship network of co-authors of Yanping Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanping Hu. A scholar is included among the top collaborators of Yanping Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanping Hu. Yanping Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Congying, Yanchun Wang, Qingtian Li, et al.. (2025). The value of serum tumor-associated autoantibodies in screening and diagnosis of gastric cancer. Clinica Chimica Acta. 569. 120167–120167.
2.
Tang, Xianqiang, et al.. (2025). Suppressing sediment nutrient release via electrokinetic drainage of porewater: apparent paradox and underlying mechanisms. Journal of Environmental Management. 383. 125492–125492.
3.
Hu, Yanping, Jingyan Liu, Jiang Xu, et al.. (2025). Functionalized Lignin Enables Co-Cross-Linking of Natural Rubber and Simultaneous Carbon Black Dispersion. ACS Applied Polymer Materials. 8(1). 420–430.
4.
Hu, Yanping, et al.. (2025). CXCL Gene Clusters Regulated by Enhancer‐Mediated DNA Looping Alteration in Pancreatic Cancer Cells. Journal of Cellular and Molecular Medicine. 29(7). e70538–e70538.
5.
Chen, Huajun, Hai‐Yan Tu, Yanping Hu, et al.. (2025). A phase II trial of anlotinib plus EGFR-TKIs in advanced non-small cell lung cancer with gradual, oligo, or potential progression after EGFR-TKIs treatment (CTONG-1803/ALTER-L001). Journal of Hematology & Oncology. 18(1). 3–3. 3 indexed citations
8.
Xu, Yang, et al.. (2024). Evolution of runoff discharge patterns and risk assessment of water inrush in mountainous railroad tunnels. Natural Hazards. 120(9). 8851–8870. 2 indexed citations
9.
Li, Xue, Yating Zhang, Yanping Hu, et al.. (2024). Design of cross-linked hard carbon with high initial coulombic efficiency for sodium-ion batteries anode. Chemical Physics Letters. 856. 141651–141651. 3 indexed citations
10.
Li, Xue, et al.. (2024). Coal-based hard carbon anode for high-performance sodium ion batteries via coal-based graphene oxide as a multi-functional binder. Materials Letters. 366. 136541–136541. 8 indexed citations
11.
Hu, Yanping, et al.. (2024). Sodium Houttuyniae attenuates ferroptosis by regulating TRAF6-c-Myc signaling pathways in lipopolysaccharide-induced acute lung injury (ALI). BMC Pharmacology and Toxicology. 25(1). 63–63. 3 indexed citations
12.
13.
Wang, Li, Yurong Cheng, Jing Yang, et al.. (2022). Case Report: Addition of PD-1 Antibody Camrelizumab Overcame Resistance to Trastuzumab Plus Chemotherapy in a HER2-Positive, Metastatic Gallbladder Cancer Patient. Frontiers in Immunology. 12. 784861–784861. 6 indexed citations
14.
Wu, Jingyi, et al.. (2021). The incidence and prognosis of thymic squamous cell carcinoma. Medicine. 100(15). e25331–e25331. 13 indexed citations
16.
Chen, Fang, Yanping Hu, Nan Zhang, et al.. (2014). Astragalus polysaccharide induces apoptosis of human KG-1a cells through inhibiting PTEN-PI3K-Akt signaling pathway. 23(4). 219–222. 1 indexed citations
17.
Wang, Li, Lizhe An, Yanping Hu, Lixin Wei, & Yi Li. (2009). Influence of phytohormones and medium on the shoot regeneration from leaf of Swertia chirata Buch.-Ham. Ex wall. in vitro. AFRICAN JOURNAL OF BIOTECHNOLOGY. 8(11). 2513–2517. 19 indexed citations
18.
Dragowska, Wieslawa H., Corinna Warburton, Donald T. Yapp, et al.. (2004). HER-2/neuOverexpression Increases the Viable Hypoxic Cell Population within Solid Tumors without Causing Changes in Tumor Vascularization. Molecular Cancer Research. 2(11). 606–619. 23 indexed citations
19.
Krishan, Awtar, Kasi S. Sridhar, Wilfred D. Stein, et al.. (2000). Synergistic effect of prochlorperazine and dipyridamole on the cellular retention and cytotoxicity of doxorubicin.. PubMed. 6(4). 1508–17. 9 indexed citations
20.
Hu, Yanping, et al.. (1995). Failure of liposomal encapsulation of doxorubicin to circumvent multidrug resistance in an in vitro model of rat glioblastoma cells. European Journal of Cancer. 31(3). 389–394. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026